Natural killer cells as a potential biomarker for predicting immunotherapy efficacy in patients with non-small cell lung cancer

YH Cho, MG Choi, DH Kim, YJ Choi, SY Kim, KJ Sung… - Targeted …, 2020 - Springer
Background Immunotherapy with immune checkpoint inhibitors for non-small cell lung
cancer (NSCLC) has emerged as an important treatment option. Although immunotherapy …
被引用次数：48 相关文章

[引用][C] Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

YH Cho, MG Choi, DH Kim, YJ Choi, SY Kim… - Targeted …, 2020 - cir.nii.ac.jp
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients
with Non-Small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

C Yong-Hee, MG Choi, KD Ha, YJ Choi… - Targeted …, 2020 - search.proquest.com
Background Immunotherapy with immune checkpoint inhibitors for non-small cell lung
cancer (NSCLC) has emerged as an important treatment option. Although immunotherapy …

Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer.

YH Cho, MG Choi, DH Kim, YJ Choi, SY Kim… - Targeted …, 2020 - europepmc.org
Background Immunotherapy with immune checkpoint inhibitors for non-small cell lung
cancer (NSCLC) has emerged as an important treatment option. Although immunotherapy …

Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

YH Cho, MG Choi, DH Kim, YJ Choi… - Targeted …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Immunotherapy with immune checkpoint inhibitors for non-small cell lung
cancer (NSCLC) has emerged as an important treatment option. Although immunotherapy …